USD 1.94
(-11.82%)
Year | Inventory | Inventory Growth |
---|---|---|
2023 | - USD | 0.0% |
2022 | - USD | 100.0% |
2021 | -43.66 Thousand USD | 0.0% |
2020 | - USD | 0.0% |
2019 | - USD | 0.0% |
Year | Inventory | Inventory Growth |
---|---|---|
2024 Q1 | 1.00 USD | 0.0% |
2024 Q2 | - USD | -100.0% |
2023 Q2 | - USD | 0.0% |
2023 FY | - USD | 0.0% |
2023 Q4 | - USD | 0.0% |
2023 Q3 | - USD | 0.0% |
2023 Q1 | - USD | 0.0% |
2022 Q4 | - USD | 100.0% |
2022 Q3 | -255.3 Thousand USD | -25.67% |
2022 FY | - USD | 100.0% |
2022 Q2 | -203.15 Thousand USD | 0.0% |
2022 Q1 | - USD | 0.0% |
2021 Q1 | - USD | 0.0% |
2021 FY | -43.66 Thousand USD | 0.0% |
2021 Q4 | - USD | 0.0% |
2021 Q3 | - USD | 0.0% |
2020 FY | - USD | 0.0% |
2020 Q4 | - USD | 0.0% |
2019 FY | - USD | 0.0% |
Name | Inventory | Inventory Difference |
---|---|---|
AIM ImmunoTech Inc. | -1.18 Million USD | 100.0% |
Ampio Pharmaceuticals, Inc. | 1.00 USD | 100.0% |
Armata Pharmaceuticals, Inc. | - USD | NaN% |
Actinium Pharmaceuticals, Inc. | - USD | NaN% |
Azitra, Inc. | -215.21 Thousand USD | 100.0% |
Can-Fite BioPharma Ltd. | - USD | NaN% |
Chromocell Therapeutics Corporation | - USD | NaN% |
Calidi Biotherapeutics, Inc. | - USD | NaN% |
CEL-SCI Corporation | 2.24 Million USD | 100.0% |
iBio, Inc. | - USD | NaN% |
Lineage Cell Therapeutics, Inc. | - USD | NaN% |
Matinas BioPharma Holdings, Inc. | - USD | NaN% |
Navidea Biopharmaceuticals, Inc. | 427.34 Thousand USD | 100.0% |
NovaBay Pharmaceuticals, Inc. | 2.87 Million USD | 100.0% |
NanoViricides, Inc. | - USD | NaN% |
Oragenics, Inc. | - USD | NaN% |
BiomX Inc. | - USD | NaN% |
BiomX Inc. | - USD | NaN% |
Protalix BioTherapeutics, Inc. | 19.04 Million USD | 100.0% |
Palatin Technologies, Inc. | - USD | NaN% |
Scorpius Holdings, Inc. | 909.15 Thousand USD | 100.0% |